![](/img/cover-not-exists.png)
Safety and Efficacy of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease: 2 Years of Treatment in Phase III Trials and an Extension Study
Ari Zimran, Madhulika Kabra, Pilar Giraldo, Marie-Françoise Ben Dridi, Deborah Elstein, Neerja Gupta, David Zahrieh, Eric Crombez, Hadhami Ben TurkiaVolume:
105
Year:
2012
Language:
english
DOI:
10.1016/j.ymgme.2011.11.187
File:
PDF, 50 KB
english, 2012